The prevalence of XXXX ( @entity1277 ) and comorbid @entity146 in adolescents: a two-stage community-based study.

@entity1 @entity308 @entity146 @entity913 @entity1278 @entity148 @entity2613 @entity1277 @entity74 @entity5550
OBJECTIVE: The aims of this study were to determine the prevalence of @entity1277 ( @entity1277 ) in adolescents and the prevalence of comorbid @entity146 in adolescents with @entity1277 . METHOD: During stage 1 of the study the Eating Attitude Test (EAT) was administered to 2907 randomly selected adolescent students. During stage 2 of the study students with an EAT score >30 underwent a clinical interview and those diagnosed with an @entity2613 (based on DSM-IV criteria) were included in the @entity2613 group. The control group included students that were age- and sex-matched with the @entity2613 group, were not diagnosed with an @entity2613 , and had an EAT score <30. Psychiatric comorbidity in the @entity2613 and control groups was evaluated using the Structured Clinical Interview for DSM-III-R (outpatient and non- @entity1 forms). Additionally, a demographic data form, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI) were administered to all the @entity1 . RESULTS: In total, 68 (9 male and 59 female) of the 2907 students met the diagnostic criteria for an @entity2613 . Point prevalence rates were as follows: @entity1278 : 0.034%; bulimia nervosa: 0.79%: eating disorder not otherwise specified: 1.51%; @entity5550 : 0.99%; any @entity2613 : 2.33%. None of the male @entity1 were diagnosed with @entity1278 . In all, 8 male students were diagnosed with @entity5550 . The prevalence of comorbid @entity146 was higher in the @entity2613 group. @entity308 was the most prevalent @entity74 in the @entity2613 group, followed by @entity148 and @entity913 . The body mass index, and BDI, BAI, and EAT scores were higher in the @entity2613 group than in the control group. CONCLUSION: The results of this study show that whereas the point prevalence rate for @entity1277 among all the @entity1 was 2.3%, it was 4.03% among the female @entity1 . Moreover, @entity2613 not otherwise specified was the most prevalent @entity2613 , and @entity5550 was the most common @entity2613 among the males. The prevalence rates in the present study are similar to those observed in Western countries, except for the prevalence rate for @entity1278 , which in the present study was lower. @entity308 and @entity148 were the most prevalent @entity74 in the @entity2613 group.
